Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Onay, Ummiye V ^a   Aaltonen, Kirsimari ^b   Briollais, Laurent ^a,c   Knight, Julia A ^a,c   Pabalan, Noel ^a   Kilpivaara, Outi ^b   Andrulis, Irene L ^a,d,e   Blomqvist, Carl ^b   Nevanlinna, Heli ^b   Ozcelik, Hilmi ^a,e  

^a MOUNT SINAI HOSPITAL   (Canada)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF TORONTO   (Canada)

^d CANCER CARE ONTARIO   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CATECHOL METHYLTRANSFERASE; GLYCINE; METHIONINE; PROLINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CCND1; VALINE; CYCLIN D; CYCLINE;

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; CANADA; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FINLAND; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR GENETICS; POPULATION; RISK ASSESSMENT; BREAST TUMOR; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; CYCLINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 40049094854     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-6     Document Type: Article

References (48)

1. Clarke R Dickson RB Lippman ME Hormonal aspects of breast cancer. Growth factors, drugs and stromal interactions Crit Rev Oncol Hematol 1992, 12:1-23. 10.1016/1040-8428(92)90062-U 1540336
2. Zhu BT Conney AH Functional role of estrogen metabolism in target cells: review and perspectives Carcinogenesis 1998, 19:1-27. 10.1093/carcin/ 19.1.1 9472688
3. Spink DC Eugster HP Lincoln DW 2nd Schuetz JD Schuetz EG Johnson JA Kaminsky LS Gierthy JF 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1A1: A comparison of the activities induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA Arch Biochem Biophys 1992, 293:342-348. 10.1016/0003-9861(92)90404-K 1536570
4. Hayes CL Spink DC Spink BC Cao JQ Walker NJ Sutter TR 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1 Proc Natl Acad Sci U S A 1996, 93:9776-9781. 38505 8790407 10.1073/pnas.93.18.9776
5. Zhu BT Catechol-O-Methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: Importance in pathophysiology and pathogenesis Curr Drug Metab 2002, 3:321-349. 10.2174/1389200023337586 12083324
6. Tenhunen J Heikkila P Alanko A Heinonen E Akkila J Ulmanen I Soluble and membrane-bound catechol-O-methyltransferase in normal and malignant mammary gland Cancer Lett 1999, 144:75-84. 10.1016/S0304-3835(99)00197-4 10503880
7. Weinshilboum R Dunnette J Thermal stability and the biochemical genetics of erythrocyte catechol-O-methyl-transferase and plasma dopamine-beta-hydroxylase Clin Genet 1981, 19:426-437. 7296933
8. Boudikova B Szumlanski C Maidak B Weinshilboum R Human liver catechol-O-methyltransferase pharmacogenetics Clin Pharmacol Ther 1990, 48:381-389. 2225698
9. Lotta T Vidgren J Tilgmann C Ulmanen I Melen K Julkunen I Taskinen J Kinetics of human soluble and membrane-bound catechol O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme Biochemistry 1995, 34:4202-4210. 10.1021/bi00013a008 7703232
10. Lachman HM Papolos DF Saito T Yu YM Szumlanski CL Weinshilboum RM Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders Pharmacogenetics 1996, 6:243-250. 10.1097/ 00008571-199606000-00007 8807664
11. Foster JS Henley DC Ahamed S Wimalasena J Estrogens and cell-cycle regulation in breast cancer Trends Endocrinol Metab 2001, 12:320-327. 10.1016/S1043-2760(01)00436-2 11504672
12. Bartkova J Lukas J Strauss M Bartek J Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis Oncogene 1995, 10:775-778. 7862456
13. Doisneau-Sixou SF Sergio CM Carroll JS Hui R Musgrove EA Sutherland RL Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells Endocr Relat Cancer 2003, 10:179-186. 10.1677/erc.0.0100179 12790780
14. Diehl JA Cycling to cancer with cyclin D1 Cancer Biol Ther 2002, 1:226-231. 12432268
15. Betticher DC Thatcher N Altermatt HJ Hoban P Ryder WD Heighway J Alternate splicing produces a novel cyclin D1 transcript Oncogene 1995, 11:1005-1011. 7675441
16. Diehl JA Sherr CJ A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase Mol Cell Biol 1997, 17:7362-7374. 232592 9372967
17. Alt JR Cleveland JL Hannink M Diehl JA Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation Genes Dev 2000, 14:3102-3114. 317128 11124803 10.1101/ gad.854900
18. Lu F Gladden AB Diehl JA An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene Cancer Res 2003, 63:7056-7061. 14612495
19. Onay VU Briollais L Knight JA Shi E Wang Y Wells S Li H Rajendram I Andrulis IL Ozcelik H SNP-SNP interactions in breast cancer susceptibility BMC Cancer 2006, 6:114. 1522021 16672066 10.1186/ 1471-2407-6-114
20. Knight JA Sutherland HJ Glendon G Boyd NF Andrulis IL Characteristics associated with participation at various stages at the Ontario site of the cooperative family registry for breast cancer studies Ann Epidemiol 2002, 12:27-33. 10.1016/S1047-2797(01)00253-8 11750237
21. John EM Hopper JL Beck JC Knight JA Neuhausen SL Senie RT Ziogas A Andrulis IL Anton-Culver H Boyd N Buys SS Daly MB O'Malley FP Santella RM Southey MC Venne VL Venter DJ West DW Whittemore AS Seminara D The Breast Cancer Family Registry: An infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer Breast Cancer Res 2004, 6:R375-89. 468645 15217505 10.1186/bcr801
22. Syrjakoski K Vahteristo P Eerola H Tamminen A Kivinummi K Sarantaus L Holli K Blomqvist C Kallioniemi OP Kainu T Nevanlinna H Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients J Natl Cancer Inst 2000, 92:1529-1531. 10.1093/jnci/ 92.18.1529 10995809
23. Kilpivaara O Bartkova J Eerola H Syrjakoski K Vahteristo P Lukas J Blomqvist C Holli K Heikkila P Sauter G Kallioniemi OP Bartek J Nevanlinna H Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients Int J Cancer 2005, 113:575-580. 10.1002/ijc.20638 15472904
24. Livak KJ Allelic discrimination using fluorogenic probes and the 5′ nuclease assay Genet Anal 1999, 14:143-149. 10084106
25. Tommiska J Eerola H Heinonen M Salonen L Kaare M Tallila J Ristimaki A von Smitten K Aittomaki K Heikkila P Blomqvist C Nevanlinna H Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival Clin Cancer Res 2005, 11:5098-5103. 10.1158/ 1078-0432.CCR-05-0173 16033823
26. Gauderman WJ Sample size requirements for association studies of gene-gene interaction Am J Epidemiol 2002, 155:478-484. 10.1093/aje/ 155.5.478 11867360
27. Abramson J Gahlinger P Computer programs for epidemiologists. PEPI version4.0. Salt Lake City, Utah Sagebrush Press; 2001.
28. Bewick V Cheek L Ball J Statistics review 8: Qualitative data - tests of association Crit Care 2004. 8:46-53. 420070 14975045 10.1186/cc2428
29. Mantel N Haenszel W Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 1959, 22:719-748. 13655060
30. DerSimonian R Laird N Meta-analysis in clinical trials Control Clin Trials 1986, 7:177-188. 10.1016/0197-2456(86)90046-2 3802833
31. Lau J Ioannidis JP Schmid CH Quantitative synthesis in systematic reviews Ann Intern Med 1997, 127:820-826. 9382404
32. Higgins JP Thompson SG Deeks JJ Altman DG Measuring inconsistency in meta-analyses Bmj 2003, 327:557-560. 192859 12958120 10.1136/ bmj.327.7414.557
33. Berman NG Parker RA Meta-analysis: Neither quick nor easy BMC Med Res Methodol 2002, 2:10. 122061 12171604 10.1186/1471-2288-2-10
34. Ahsan H Chen Y Whittemore AS Kibriya MG Gurvich I Senie RT Santella RM A family-based genetic association study of variants in estrogen-metabolism genes COMT and CYP1B1 and breast cancer risk Breast Cancer Res Treat 2004, 85:121-131. 10.1023/B:BREA.0000025401.60794.68 15111770
35. Akisik E Dalay N Functional polymorphism of thymidylate synthase, but not of the COMT and IL-1B genes, is associated with breast cancer J Clin Lab Anal 2007, 21:97-102. 10.1002/jcla.20139 17385677
36. Gaudet MM Bensen JT Schroeder J Olshan AF Terry MB Eng SM Teitelbaum SL Britton JA Lehman TA Neugut AI Ambrosone CB Santella RM Gammon MD Catechol-O-methyltransferase haplotypes and breast cancer among women on Long Island, New York Breast Cancer Res Treat 2006, 99:235-240. 10.1007/ s10549-006-9205-0 16596327
37. Kocabas NA Sardas S Cholerton S Daly AK Karakaya AE Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population Arch Toxicol 2002, 76:643-649. 10.1007/s00204-002-0387-x 12415427
38. Lavigne JA Helzlsouer KJ Huang HY Strickland PT Bell DA Selmin O Watson MA Hoffman S Comstock GW Yager JD An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer Cancer Res 1997, 57:5493-5497. 9407957
39. Millikan RC Pittman GS Tse CK Duell E Newman B Savitz D Moorman PG Boissy RJ Bell DA Catechol-O-methyltransferase and breast cancer risk Carcinogenesis 1998, 19:1943-1947. 10.1093/carcin/19.11.1943 9855007
40. Mitrunen K Jourenkova N Kataja V Eskelinen M Kosma VM Benhamou S Kang D Vainio H Uusitupa M Hirvonen A Polymorphic catechol-O-methyltransferase gene and breast cancer risk Cancer Epidemiol Biomarkers Prev 2001, 10:635-640. 11401913
41. Sazci A Ergul E Utkan NZ Canturk NZ Kaya G Catechol-O-methyltransferase Val 108/158 Met polymorphism in premenopausal breast cancer patients Toxicology 2004, 204:197-202. 10.1016/j.tox.2004.06.026 15388245
42. Wedren S Rudqvist TR Granath F Weiderpass E Ingelman-Sundberg M Persson I Magnusson C Catechol-O-methyltransferase gene polymorphism and post-menopausal breast cancer risk Carcinogenesis 2003, 24:681-687. 10.1093/carcin/bgg022 12727796
43. Thompson PA Shields PG Freudenheim JL Stone A Vena JE Marshall JR Graham S Laughlin R Nemoto T Kadlubar FF Ambrosone CB Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk Cancer Res 1998, 58:2107-2110. 9605753
44. Grieu F Malaney S Ward R Joseph D Iacopetta B Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers Anticancer Res 2003, 23:4257-4259. 14666635
45. Krippl P Langsenlehner U Renner W Yazdani-Biuki B Wolf G Wascher TC Paulweber B Weitzer W Leithner A Samonigg H The 870G>A polymorphism of the cyclin D1 gene is not associated with breast cancer Breast Cancer Res Treat 2003, 82:165-168. 10.1023/B:BREA.0000004372.20461.33 14703063
46. Forsti A Angelini S Festa F Sanyal S Zhang Z Grzybowska E Pamula J Pekala W Zientek H Hemminki K Kumar R Single nucleotide polymorphisms in breast cancer Oncol Rep 2004, 11:917-922. 15010895
47. Dawling S Roodi N Parl FF Methoxyestrogens exert feedback inhibition on cytochrome P450 1A1 and 1B1 Cancer Res 2003, 63:3127-3132. 12810639
48. Tsutsui T Tamura Y Hagiwara M Miyachi T Hikiba H Kubo C Barrett JC Induction of mammalian cell transformation and genotoxicity by 2-methoxyestradiol, an endogenous metabolite of estrogen Carcinogenesis 2000, 21:735-740. 10.1093/carcin/21.4.735 10753210